Comparison of pituitary-adrenocortical function in asthmatic patients given long-term corticosteroid therapy and in asthmatics who have not received adrenal steroids.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001623:Betamethasone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003346:Corticotropin-Releasing Hormone; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013997:Time Factors; D014221:Triamcinolone / Q000627:therapeutic use
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D014221:Triamcinolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D001623:Betamethasone; D011239:Prednisolone; D011241:Prednisone; D008797:Metyrapone